Short Stature, Idiopathic
2 clinical trials · Condition
◉ Watch Short Stature, Idiopathic
| Record | Firm | Date |
|---|---|---|
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. (NCT03015909) | LG Life Sciences | 2016-08-11 |
| Pappalysin 2 (PAPP-A2) Enzyme Replacement (NCT02412943) | Children's Hospital Medical Center, Cincinnati | 2015-04-01 |
Track Short Stature, Idiopathic automatically
Every clearance here is in the API, with alerts when new ones post.